Recent data indicates that retatrutide, a innovative medication, could represent a significant improvement in weight reduction . This drug combines the effects of a GLP-1 receptor and a GIP analog, potentially offering a more impact than available approaches . Study assessments have demonstrated encouraging findings , including substantial decrease